Related references
Note: Only part of the references are listed.Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
Karl H. Plate et al.
ACTA NEUROPATHOLOGICA (2012)
VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
Kan V. Lu et al.
CANCER CELL (2012)
A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma
Ashwatha Narayana et al.
JOURNAL OF NEUROSURGERY (2012)
Bevacizumab Does Not Increase the Risk of Remote Relapse in Malignant Glioma
Antje Wick et al.
ANNALS OF NEUROLOGY (2011)
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
Olivier Keunen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Dasatinib Inhibits the Development of Metastases in a Mouse Model of Pancreatic Ductal Adenocarcinoma
Jennifer P. Morton et al.
GASTROENTEROLOGY (2010)
Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
John F. de Groot et al.
NEURO-ONCOLOGY (2010)
Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype
Laura J. Lewis-Tuffin et al.
PLOS ONE (2010)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Fyn and Src Are Effectors of Oncogenic Epidermal Growth Factor Receptor Signaling in Glioblastoma Patients
Kan V. Lu et al.
CANCER RESEARCH (2009)
Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
Jinyan Du et al.
NATURE BIOTECHNOLOGY (2009)
Endosomal NADPH oxidase regulates c-Src activation following hypoxia/reoxygenation injury
Qiang Li et al.
BIOCHEMICAL JOURNAL (2008)
Treatment with bevacizumab and irinotecan for recurrent high-grade glial tumors
Felix Bokstein et al.
CANCER (2008)
Yes and PI3K bind CD95 to signal invasion of glioblastoma
Susanne Kleber et al.
CANCER CELL (2008)
Targeting src family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model
Serk In Park et al.
CANCER RESEARCH (2008)
PTEN loss does not predict for response to RAD001 (everolimus) in a glioblastoma orthotopic xenograft test panel
Lin Yang et al.
CLINICAL CANCER RESEARCH (2008)
Metabolism and disposition of dasatinib after oral administration to humans
Lisa J. Christopher et al.
DRUG METABOLISM AND DISPOSITION (2008)
p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression
Edwin Soto et al.
JOURNAL OF CELL BIOLOGY (2008)
Bevacizumab and irinotecan therapy in glioblastoma multiforme: a series of 13 cases
Sheikh A. Ali et al.
JOURNAL OF NEUROSURGERY (2008)
SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells
Adina Vultur et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Bevacizumab for recurrent malignant gliomas - Efficacy, toxicity, and patterns of recurrence
A. D. Norden et al.
NEUROLOGY (2008)
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
James J. Vredenburgh et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2
Tiana A. Garrett et al.
EXPERIMENTAL CELL RESEARCH (2007)
Dual role of mitochondrial reactive oxygen species in hypoxia signaling:: Activation of nuclear factor-κB via c-SRC- and oxidant-dependent cell death
Josep M. Lluis et al.
CANCER RESEARCH (2007)
Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on Src kinase for survival
Audrey C. Shor et al.
CANCER RESEARCH (2007)
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel
Jann N. Sarkaria et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma
James J. Vredenburgh et al.
CLINICAL CANCER RESEARCH (2007)
A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo
Houda Jallal et al.
CANCER RESEARCH (2007)
Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib
Alan Serrels et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-κB and correlate with poor patient outcome
Nhan L. Tran et al.
CANCER RESEARCH (2006)
Integrin-regulated FAK-Src signaling in normal and cancer cells
Satyajit K. Mitra et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
p120 catenin is essential for mesenchymal cadherin-mediated regulation of cell motility and invasiveness
Masahiro Yanagisawa et al.
JOURNAL OF CELL BIOLOGY (2006)
Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways
Chang-Min Park et al.
CANCER RESEARCH (2006)
Reduced glioma infiltration in Src-deficient mice
Caren V. Lund et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response
JN Sarkaria et al.
CLINICAL CANCER RESEARCH (2006)
SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of β-catenin and its nuclear signaling
AML Coluccia et al.
CANCER RESEARCH (2006)
Rho GTPases and the control of cell behaviour
A Hall
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells
S Nam et al.
CANCER RESEARCH (2005)
Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1
B Salhia et al.
CANCER RESEARCH (2005)
Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells
FM Johnson et al.
CLINICAL CANCER RESEARCH (2005)
SKI-606, a Src/AbI inhibitor with in vivo activity in colon tumor xenograft models
JM Golas et al.
CANCER RESEARCH (2005)
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme
C Giannini et al.
NEURO-ONCOLOGY (2005)
Newest findings on the oldest oncogene;: how activated src does it
MC Frame
JOURNAL OF CELL SCIENCE (2004)
FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly
DJ Webb et al.
NATURE CELL BIOLOGY (2004)
Discovery of N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays
LJ Lombardo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Cell adhesion receptors, tyrosine kinases and actin modulators: a complex three-way circuitry
VG Brunton et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
Src family kinases, key regulators of signal transduction
SJ Parsons et al.
ONCOGENE (2004)
The interplay between Src and integrins in normal and tumor biology
MP Playford et al.
ONCOGENE (2004)
The pattern of enhancement of Src kinase activity on platelet-derived growth factor stimulation of glioblastoma cells is affected by the integrin engaged
Q Ding et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Translocation of CrkL to focal adhesions mediates integrin-induced migration downstream of Src family kinases
LM Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Regulation of Rho GTPases by p120-catenin
PZ Anastasiadis et al.
CURRENT OPINION IN CELL BIOLOGY (2001)
Identification of Src phosphorylation sites in the catenin p120ctn
DJ Mariner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
p120 catenin regulates the actin cytoskeleton via Rho family GTPases
NK Noren et al.
JOURNAL OF CELL BIOLOGY (2000)
Molecular events implicated in brain tumor angiogenesis and invasion
D Zagzag et al.
PEDIATRIC NEUROSURGERY (2000)
Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption
JL Rubenstein et al.
NEOPLASIA (2000)
Share Paper
